{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:08:32Z","timestamp":1649088512823},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1097\/mot.0000000000000336","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T13:52:12Z","timestamp":1464875532000},"page":"447-452","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors associated with the development of histocompatibility leukocyte antigen sensitization"],"prefix":"10.1097","volume":"21","author":[{"given":"Stanley C.","family":"Jordan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jua","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Vo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kahwaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20211004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"R2-18-20211004","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.2215\/CJN.01230211","article-title":"Monitoring and managing graft health in the kidney transplant recipient","volume":"6","author":"Josephson","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-18-20211004","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R5-18-20211004","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"R6-18-20211004","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"R7-18-20211004","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"R8-18-20211004","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1600-6143.2008.02262.x","article-title":"The spectrum of antibody-mediated renal allograft injury: implications for treatment","volume":"8","author":"Gloor","year":"2008","journal-title":"Am J Transplant"},{"key":"R9-18-20211004","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1993.03510110079036","article-title":"Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients","volume":"270","author":"Port","year":"1993","journal-title":"JAMA"},{"key":"R10-18-20211004","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/TP.0000000000000525","article-title":"Factors predicting risk for antibody-mediated rejection and graft loss in highly human leukocyte antigen sensitized patients transplanted after desensitization","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"R11-18-20211004","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching: a strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"key":"R12-18-20211004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1681\/ASN.2015060608","article-title":"Donor-specific HLA antibody IgG subclasses are associated with phenotypes of antibody-mediated rejection in sensitized renal allograft recipients","volume":"27","author":"Jordan","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R13-18-20211004","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R14-18-20211004","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R15-18-20211004","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"R16-18-20211004","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-18-20211004","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2217\/imt.15.10","article-title":"Achieving incompatible transplantation through desensitization: current perspectives and future directions","volume":"7","author":"Jordan","year":"2015","journal-title":"Immunotherapy"},{"key":"R18-18-20211004","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJMoa1508380","article-title":"Survival benefit with kidney transplants from HLA-incompatible live donors","volume":"374","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"R19-18-20211004","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"R20-18-20211004","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy, outcomes, and cost-effectiveness of desensitization using IVIg and rituximab","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"key":"R21-18-20211004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R22-18-20211004","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1600-6143.2011.03525.x","article-title":"Summary of FDA antibody-mediated rejection workshop","volume":"11","author":"Archdeacon","year":"2011","journal-title":"Am J Transplant"},{"key":"R23-18-20211004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/tri.12160","article-title":"B-cell regulation and its application to transplantation","volume":"27","author":"Clatworthy","year":"2014","journal-title":"Transpl Int"},{"key":"R24-18-20211004","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/BOR.0000000000000000","article-title":"B cells: depletion or functional modulation in rheumatic diseases","volume":"26","author":"D\u00f6rner","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R25-18-20211004","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2012.11.020","article-title":"Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype","volume":"38","author":"Baumjohann","year":"2013","journal-title":"Immunity"},{"key":"R26-18-20211004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/iji.12106","article-title":"T helper subsets & regulatory T cells: rethinking the paradigm in the clinical context of solid organ transplantation","volume":"41","author":"Askar","year":"2014","journal-title":"Int J Immunogenet"},{"key":"R27-18-20211004","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1111\/ajt.13393","article-title":"Intrarenal B cell cytokines promote transplant fibrosis and tubular atrophy","volume":"15","author":"Tse","year":"2015","journal-title":"Am J Transplant"},{"key":"R28-18-20211004","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.4049\/jimmunol.1003774","article-title":"Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells","volume":"187","author":"Fogal","year":"2011","journal-title":"J Immunol"},{"key":"R29-18-20211004","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.4049\/jimmunol.1100766","article-title":"IL-6 promotes cardiac graft rejection mediated by CD4+ cells","volume":"187","author":"Booth","year":"2011","journal-title":"J Immunol"},{"key":"R30-18-20211004","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.4049\/jimmunol.1401190","article-title":"Cutting edge: circulating plasmablasts induce the differentiation of human T follicular helper cells via IL-6 production","volume":"194","author":"Chavele","year":"2015","journal-title":"J Immunol"},{"key":"R31-18-20211004","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/TP.0b013e31827be3c1","article-title":"Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA","volume":"95","author":"Zachary","year":"2013","journal-title":"Transplantation"},{"key":"R32-18-20211004","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-6143.2011.03830.x","article-title":"Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory period","volume":"12","author":"Kohei","year":"2012","journal-title":"Am J Transplant"},{"key":"R33-18-20211004","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/ajt.12308","article-title":"Cryptic B cell response to renal transplantation","volume":"13","author":"Lynch","year":"2013","journal-title":"Am J Transplant"},{"key":"R34-18-20211004","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"key":"R35-18-20211004","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/TP.0000000000000064","article-title":"Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients","volume":"98","author":"Vo","year":"2014","journal-title":"Transplantation"},{"key":"R36-18-20211004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"R38-18-20211004","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.4049\/jimmunol.1500940","article-title":"Cutting edge: CTLA-4Ig inhibits memory B-cell responses and promotes allograft survival in sensitized recipients","volume":"195","author":"Chen","year":"2015","journal-title":"J Immunol"},{"key":"R39-18-20211004","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1681\/ASN.2012070664","article-title":"Donor-specific antibodies adversely affect kidney allograft outcomes","volume":"23","author":"Mohan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R40-18-20211004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrneph.2013.18","article-title":"Transplantation: donor-specific HLA antibodies and renal allograft failure","volume":"9","author":"Loupy","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R41-18-20211004","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/TP.0b013e31817fdddb","article-title":"Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant","volume":"86","author":"Opelz","year":"2008","journal-title":"Transplantation"},{"key":"R42-18-20211004","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1432-2277.2011.01241.x","article-title":"Impact of maintenance immunosuppressive regimens: balance between graft protective suppression of immune functions and a near physiological immune response","volume":"24","author":"Weimer","year":"2011","journal-title":"Transpl Int"},{"key":"R43-18-20211004","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1681\/ASN.2014121234","article-title":"Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients","volume":"26","author":"Hricik","year":"2015","journal-title":"J Am Soc Nephrol"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201608000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T18:49:02Z","timestamp":1633546142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201608000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0000000000000336","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}